• Listed Companies
  • Announcements
  • TIANJIN DEV
  • EN
  • 繁
  • 简
  • Mar 28, 2024
    06:05

    An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

    Overseas Regulatory Announcement - Other

    00882 - TIANJIN DEV


  • Mar 27, 2024
    12:26

    List of Directors and their Roles and Functions

    List of Directors and their Role and Function

    00882 - TIANJIN DEV


  • Mar 27, 2024
    12:20

    Change of Chairman of the Board, Authorised Representative and Change in Composition of Nomination Committee, Remuneration Committee and Investment Committee

    Change of Remuneration Committee Member

    00882 - TIANJIN DEV


  • Mar 27, 2024
    12:14

    Final Dividend for the year ended 31 December 2023

    Dividend or Distribution (Announcement Form)

    00882 - TIANJIN DEV


  • Mar 27, 2024
    12:09

    Annoucement of Final Results for the year ended 31 December 2023

    Amendment of Constitutional Documents

    00882 - TIANJIN DEV


  • Mar 22, 2024
    06:10

    Audited Financial Results for the year ended 31 December 2023 of Tianjin Lisheng Pharmaceutical Co., Ltd.

    Results of a Subsidiary

    00882 - TIANJIN DEV


  • Mar 15, 2024
    19:12

    Date of Board Meeting

    Date of Board Meeting

    00882 - TIANJIN DEV


  • Mar 14, 2024
    17:42

    Material Variation of the Terms of Connected Transaction in relation to the Partnership Agreement

    Variation to Terms

    00882 - TIANJIN DEV


  • ‹
  • 1
  • 2
  • ...
  • 5
  • 6
  • 7
  • ...
  • 57
  • 58
  • ›
  • »

Address

1/F, China Building,
29 Queen's Road Central, Hong Kong
(852) 3693 2688
info@cre8corp.com

Sitemap

  • Listed Companies
  • Disclaimer
  • Privacy Policy

Newsletter

Fill your email and sign up for monthly newsletter to keep updated

© Cre8ir 2025 All right reserved.